In the Search of Noninvasive Methods Delineating Left Bundle Branch Block Amendable With Conduction System Pacing

Tadej Žlahtič1,2, Vito Starc2, David Žižek1,2

  • 1University Medical Centre Ljubljana, Ljubljana, Slovenia.

Insights

Conduction system pacing (CSP) shows promise for cardiac resynchronization therapy (CRT). Analyzing equivalent dipole trajectories in patients with left bundle branch block (LBBB) can identify those best suited for CSP, improving CRT outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Conduction system pacing (CSP) is an emerging cardiac resynchronization therapy (CRT) but is ineffective for approximately one-third of patients with left bundle branch block (LBBB) due to distal conduction disease.
  • Tailored patient selection for CRT is crucial, necessitating advanced analysis of ventricular depolarization patterns.

Purpose of the Study:

  • To evaluate the utility of equivalent dipole (ED) trajectories derived from high-resolution electrocardiograms (hrECGs) in differentiating proximal LBBB (pLBBB) from distal LBBB (dLBBB).
  • To assess the correlation between ED trajectory characteristics and CRT response in heart failure patients with LBBB undergoing CSP.

Main Methods:

  • Retrospective analysis of 12-lead hrECGs, ED trajectories, and echocardiograms in 18 heart failure patients with LBBB indicated for CRT and randomized to CSP.
  • Patients were categorized into pLBBB and dLBBB groups based on left bundle branch capture and left ventricular activation time.
  • Comparison of baseline characteristics, ED trajectory parameters (direction, velocity), QRS duration, and echocardiographic measures post-6 months of CRT.

Main Results:

  • The pLBBB group (n=12) exhibited distinct ED trajectories with an initial leftward direction (p=0.03) and slower, uniform velocity (p<0.001) compared to the dLBBB group (n=6).
  • Patients in the pLBBB group demonstrated significantly greater QRS duration shortening (26% vs. 14%, p<0.02) and improved left ventricular volumes (41.3% vs. 15.8%, p=0.004) and ejection fraction (17.1% vs. 5.5%, p=0.02) after 6 months.
  • ED trajectories differentiated pLBBB from dLBBB more effectively than standard 12-lead ECG criteria.

Conclusions:

  • Equivalent dipole trajectories from hrECGs offer a superior method for distinguishing proximal from distal LBBB compared to standard ECG analysis.
  • This advanced ECG analysis can aid in selecting appropriate candidates for conduction system pacing, optimizing cardiac resynchronization therapy outcomes.

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
793
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
402
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
610
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
738